Exosomal miR-92b-3p Promotes Chemoresistance of Small Cell Lung Cancer Through the PTEN/AKT Pathway

Resistance to first-line chemotherapy drugs has become an obstacle to improving the clinical prognosis of patients with small cell lung cancer (SCLC). Exosomal microRNAs have been shown to play pro- and anti-chemoresistant roles in various cancers, but their role in SCLC chemoresistance has never be...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Cell Dev Biol
Autors principals: Li, Ming, Shan, Wulin, Hua, Yan, Chao, Fengmei, Cui, Yayun, Lv, Lei, Dou, Xiaoyan, Bian, Xing, Zou, Jinglu, Li, Hong, Lin, Wenchu
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Cell and Developmental Biology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8201786/
https://ncbi.nlm.nih.gov/pubmed/34136482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2021.661602
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars